Aripiprazole Lauroxil Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 41 mg, 662 mg, 882 mg, 1064 mg

Reference Brands: Aristada (USA)

Category: Antipsychotropic Drugs

Aripiprazole Lauroxil Injection is a Antipsychotropic Drugs product available as Injection in strengths 41 mg, 662 mg, 882 mg, 1064 mg. It corresponds to the reference brand Aristada (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Aripiprazole lauroxil is a long-acting injectable atypical antipsychotic used for the treatment of schizophrenia in adults. It is a prodrug of aripiprazole, designed to provide sustained therapeutic levels over several weeks, improving adherence in patients who may have difficulty taking daily oral medications. Administered via intramuscular injection every four to eight weeks, aripiprazole lauroxil helps manage symptoms of schizophrenia, including hallucinations, delusions, disorganized thinking, and mood disturbances, by modulating dopamine and serotonin receptor activity in the brain.

Developed by Alkermes, aripiprazole lauroxil is an N-acyloxymethyl prodrug that gradually converts to active aripiprazole in the body, allowing for prolonged efficacy with fewer administrations. It provides a longer-lasting alternative to daily oral aripiprazole tablets, offering consistent symptom control and reducing the risk of relapse due to non-adherence. Aripiprazole lauroxil, like other antipsychotics in its class, is not approved for the treatment of dementia-related psychosis in elderly patients. Its extended-release formulation and predictable pharmacokinetics make it a valuable option in the long-term management of schizophrenia.